Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Benedetta Lucani"'
Autor:
alessandra serrao, benedetta lucani, davide mansour, antonietta ferretti, erminia baldacci, cristina santoro, robin foà, antonio chistolini
Publikováno v:
Mediterranean Journal of Hematology and Infectious Diseases, Vol 11, Iss 1 (2019)
Introduction: Thrombophilia is a condition that predisposes to a higher incidence of venous thromboembolisms (VTE), some also in atypical sites. Direct oral anticoagulants (DOACs) have proven to be effective in the treatment of deep vein thrombosis (
Externí odkaz:
https://doaj.org/article/674bff4b07d4407eb3418792b9a3b6d6
Autor:
Cristina Mecucci, Eleonora Miulli, Martina Quintini, Roberto Latagliata, Michela Ansuinelli, Massimo Breccia, Benedetta Lucani, Francesca Fazio, Caterina Matteucci, Fabrizia Pellanera, Ida Carmosino
Familial clustering of myeloid malignancies with autosomal dominant (AD) inheritance was firstly recognized in 1999 by the identification of germline mutations associated with familial platelet dis...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dfac79fed7f4290a66e68457380ebef9
http://hdl.handle.net/11391/1492537
http://hdl.handle.net/11391/1492537
Autor:
Alessandra Serrao, Francesca Aprile, Benedetta Lucani, Stefania Gioia, Manuela Merli, Massimo Breccia, Luciano Fiori, Olivero Riggio, Antonio Chistolini
Publikováno v:
European Journal of Clinical Investigation. 51
Background Splanchnic vein thrombosis (SVT) is an uncommon but potentially life-threatening disease usually related to different underlying clinical conditions. The risk of SVT recurrences is high over time in patients with an underlying permanent pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::060bcbc92b9ac0a6e02c847543e3660a
https://doi.org/10.1111/eci.13356
https://doi.org/10.1111/eci.13356
Publikováno v:
Phlebology. 35(9)
Mondor’s disease is a rare condition and usually treated with low-molecular weight heparin and non-steroidal anti-inflammatory drugs. Because of paucity of cases and for the usually spontaneous resolution, there is not a standard treatment strategy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1db3240b456f825c351d61981cfcc194
https://pubmed.ncbi.nlm.nih.gov/32419620
https://pubmed.ncbi.nlm.nih.gov/32419620
Autor:
Alessandra Serrao, Benedetta Lucani, Erminia Baldacci, Giovanni Manfredi, Simona Michela Aprile, Luciano Fiori, Antonio Chistolini
Anticoagulant therapy has undergone a significant change since direct oral anticoagulants (DOACs) introduction. Their obvious advantages including the fixed dose, the few interactions and less frequent controls, have made them the first choice antico
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5aea1f587b49ae25c4c652bfaa950aa2
http://hdl.handle.net/11573/1368075
http://hdl.handle.net/11573/1368075
Autor:
Steven Le Gouill, Benedetta Lucani, David Chiron, Philippe Moreau, Agnès Moreau-Aubry, Sophie Maïga, Benoit Tessoulin, Hanane Djamai, Géraldine Descamps, Martine Amiot, Pierre-Samuel Gillardin, Catherine Pellat-Deceunynck
Publikováno v:
International Journal of Molecular Sciences, Vol 19, Iss 1, p 40 (2017)
International Journal of Molecular Sciences
International Journal of Molecular Sciences, 2017, 19 (1), ⟨10.3390/ijms19010040⟩
International Journal of Molecular Sciences, MDPI, 2017, 19 (1), ⟨10.3390/ijms19010040⟩
International Journal of Molecular Sciences
International Journal of Molecular Sciences, 2017, 19 (1), ⟨10.3390/ijms19010040⟩
International Journal of Molecular Sciences, MDPI, 2017, 19 (1), ⟨10.3390/ijms19010040⟩
International audience; (1) Background: TP53 deficiency remains a major adverse event in Multiple Myeloma (MM) despite therapeutic progresses. As it is not possible to target TP53 deficiency with pharmacological agents, we explored the possibility of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::58498cce87fe2a27c9ac301bb4a6ff5b
https://www.mdpi.com/1422-0067/19/1/40
https://www.mdpi.com/1422-0067/19/1/40
Autor:
Carlo Scapellato, Francesca Scarpini, Monica Bocchia, Walter Renato Gioffre, A. Silvietti, Luca Puccetti, Francesca Santilli, Antonella Tabucchi, Francesca Fazio, Giovanni Davì, Patrizia Blardi, Lucia Terzuoli, Gianni Guazzi, Benedetta Lucani
Publikováno v:
Vascular Pharmacology. 72:16-24
Objective In patients with familial combined hyperlipidemia (FCHL), without metabolic syndrome (MS), occurrence of non-alcoholic fatty liver disease (NAFLD) is related to a specific pro-inflammatory profile, influenced by genetic traits, involved in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aac477b8244d39e9284bc6457c9b5877
https://doi.org/10.1016/j.vph.2015.04.004
https://doi.org/10.1016/j.vph.2015.04.004